These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17510038)

  • 41. Pharmacy internship: patient care experience through nursing service.
    Anderson JM; Smith JE
    Am J Hosp Pharm; 1979 Jun; 36(6):791-3. PubMed ID: 463896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Declining invasive pneumococcal disease in the U.S. elderly.
    McBean AM; Park YT; Caldwell D; Yu X
    Vaccine; 2005 Dec; 23(48-49):5641-5. PubMed ID: 16111788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced responsibilities for pharmacy interns at a teaching hospital.
    Gillis CM; Anger KE; Cotugno MC
    J Am Pharm Assoc (2003); 2015; 55(2):198-202. PubMed ID: 25699989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementing an electronically based, nurse-driven pneumococcal vaccination protocol for inpatients.
    Kishel JJ; Maguire M; Pankratz L; Julian K
    Am J Health Syst Pharm; 2009 Jul; 66(14):1304-8. PubMed ID: 19574606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integration of pharmacists into a patient-centered medical home.
    Scott MA; Hitch B; Ray L; Colvin G
    J Am Pharm Assoc (2003); 2011; 51(2):161-6. PubMed ID: 21382805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adults with invasive pneumococcal disease: missed opportunities for vaccination.
    Kyaw MH; Greene CM; Schaffner W; Ray SM; Shapiro M; Barrett NL; Gershman K; Craig AS; Roberson A; Zell ER; Schuchat A; Bennett NM; Whitney CG;
    Am J Prev Med; 2006 Oct; 31(4):286-92. PubMed ID: 16979452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Providers' beliefs, attitudes, and behaviors before implementing a computerized pneumococcal vaccination reminder.
    Dexheimer JW; Jones I; Chen Q; Talbot TR; Mason D; Aronsky D
    Acad Emerg Med; 2006 Dec; 13(12):1312-8. PubMed ID: 17101730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of two different models on influenza and pneumococcal vaccination in hospitalized patients.
    Bakare M; Shrivastava R; Jeevanantham V; Navaneethan SD
    South Med J; 2007 Feb; 100(2):140-4. PubMed ID: 17330682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Call to action on pneumococcal disease: review of vaccination evidence and outcomes of webcast programs.
    Grogg SE; Schultz J
    J Am Osteopath Assoc; 2015 Jun; 115(6 Suppl):S6-25. PubMed ID: 26000904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of candidacy for pneumococcal vaccination in intensive care patients.
    Wall GC; Van Der Veer JJ; Romine MJ; Yeager SM
    Intensive Crit Care Nurs; 2013 Aug; 29(4):212-5. PubMed ID: 23201039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a community pharmacy human papillomavirus vaccine program for underinsured university students along the United States/Mexico border.
    Navarrete JP; Padilla ME; Castro LP; Rivera JO
    J Am Pharm Assoc (2003); 2014; 54(6):642-7. PubMed ID: 25343721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.
    Fisman DN; Abrutyn E; Spaude KA; Kim A; Kirchner C; Daley J
    Clin Infect Dis; 2006 Apr; 42(8):1093-101. PubMed ID: 16575726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Designing a hospital-based pneumococcal vaccination program.
    Skledar SJ; Hess MM; Ervin KA; Gross PR; Nowalk MP; Carter H; Zimmerman RK; Middleton D
    Am J Health Syst Pharm; 2003 Jul; 60(14):1471-6. PubMed ID: 12892032
    [No Abstract]   [Full Text] [Related]  

  • 55. An emergency department-based vaccination program: overcoming the barriers for adults at high risk for vaccine-preventable diseases.
    Rimple D; Weiss SJ; Brett M; Ernst AA
    Acad Emerg Med; 2006 Sep; 13(9):922-30. PubMed ID: 16902048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving inpatient pneumococcal and influenza vaccination rates.
    Rees S; Stevens L; Drayton J; Engledow N; Sanders J
    J Nurs Care Qual; 2011; 26(4):358-63. PubMed ID: 21577146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of a pharmacist-led pneumococcal vaccine compliance program.
    King GS; Judd WR
    Am J Health Syst Pharm; 2017 Dec; 74(23):1948-1952. PubMed ID: 29167136
    [No Abstract]   [Full Text] [Related]  

  • 58. Facilitating pneumococcal vaccination among high-risk adults: Impact of an assertive communication training program for community pharmacists.
    Gatwood J; Renfro C; Hagemann T; Chiu CY; Kapan S; Frederick K; Hohmeier KC
    J Am Pharm Assoc (2003); 2021; 61(5):572-580.e1. PubMed ID: 33935021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality improvement in critical access hospitals: addressing immunizations prior to discharge.
    Ellerbeck EF; Totten B; Markello S; Patterson K; Sipe TR; Tilden C
    J Rural Health; 2003; 19(4):433-8. PubMed ID: 14526501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital.
    Mills B; Fensterheim L; Taitel M; Cannon A
    Vaccine; 2014 Jan; 32(4):521-5. PubMed ID: 24269619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.